Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00500565 · ClinicalTrials.gov registry record · NA
Pain Management Following TRAM Flap for Breast Reconstruction
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT00500565: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00500565 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00500565, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The objective of this pilot study is to examine the efficacy of the ON\~Q Pain Relief System plus Intravenous Patient Controlled Analgesia (IVPCA) with Morphine vs IV PCA alone in patients undergoing free transverse rectus abdominis musculocutaneous (TRAM) flap surgery. The primary outcome measure will be postoperative opioid analgesia requirements. Other outcomes will also be assessed, including pain scores, quality of recovery, and resource utilization.
Interventions
- DRUG Saline
- DRUG Bupivicaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2003-12 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00500565
The ClinicalTrials.gov registry entry for NCT00500565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT00500565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00500565 about?
NCT00500565 is a clinical study titled "Pain Management Following TRAM Flap for Breast Reconstruction". The objective of this pilot study is to examine the efficacy of the ON\~Q Pain Relief System plus Intravenous Patient Controlled Analgesia (IVPCA) with Morphine vs IV PCA alone in patients undergoing free transverse rectus abdominis musculocutaneous (TRAM) flap surgery. The primary outcome measure w...
What is the current status of trial NCT00500565?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2003-12. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00500565?
The interventions under investigation include: Saline (DRUG), Bupivicaine (DRUG).
Who is sponsoring clinical trial NCT00500565?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.